BioAge Labs (BIOA) Income Statement (2023 - 2026)
Income Statement report data from Mar 31, 2023 to Mar 31, 2026 for BioAge Labs (BIOA).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||||||||
Total Revenue | 2.77M (-10.06%) | 3.08M (+50.24%) | 2.05M (-14.94%) | 2.41M (+66.21%) | 1.45M | - | - | - | - | - | - | - | - |
Operating Expenses | |||||||||||||
Research And Development | 20M (-16.69%) | 25M (+32.36%) | 19M (-6.70%) | 20M (+78.58%) | 11M (-42.23%) | 19M (-3.95%) | 20M (+91.21%) | 10M (+12.34%) | 9.32M (-65.92%) | 27M (+318.84%) | 6.53M | - | - |
Selling General And Administrative | 7.74M (+10.57%) | 7.00M (+4.79%) | 6.68M (-8.99%) | 7.34M (+8.10%) | 6.79M (+10.59%) | 6.14M (+29.81%) | 4.73M (-1.46%) | 4.80M (+37.54%) | 3.49M (-68.73%) | 11M (+232.14%) | 3.36M | - | - |
Operating Expenses | 28M (-10.63%) | 32M (+25.05%) | 25M (-7.32%) | 27M (+51.84%) | 18M (-29.42%) | 25M (+2.46%) | 25M (+62.08%) | 15M (+19.20%) | 13M (-66.74%) | 39M (+289.38%) | 9.89M | - | - |
Depreciation And Amortization | - | 200K | - | - | - | 200K | - | - | - | 200K | - | - | - |
Operating Income | |||||||||||||
Operating Income | -25.37M (-10.73%) | -28.42M (+22.82%) | -23.14M (-6.58%) | -24.77M (+50.58%) | -16.45M (-35.13%) | -25.36M (+2.46%) | -24.75M (+62.08%) | -15.27M (+19.20%) | -12.81M (-66.74%) | -38.51M (+289.38%) | -9.89M | - | - |
Ebit | -25.37M (-10.73%) | -28.42M (+22.82%) | -23.14M (-6.58%) | -24.77M (+50.58%) | -16.45M (-35.13%) | -25.36M (+2.46%) | -24.75M (+62.08%) | -15.27M (+19.20%) | -12.81M (+25.10%) | -10.24M (+3.54%) | -9.89M (-42.47%) | -17.19M (+55.14%) | -11.08M |
EBITDA | -22.21M (-42.34%) | -38.52M (+92.41%) | -20.02M (-6.27%) | -21.36M (+68.59%) | -12.67M (-57.85%) | -30.06M (+30.58%) | -23.02M (+75.19%) | -13.14M (+11.64%) | -11.77M (+52.66%) | -7.71M (-36.91%) | -12.22M (-28.91%) | -17.19M (+55.14%) | -11.08M |
Other Income / Expenses | |||||||||||||
Interest Expense | 40K (-55.56%) | 90K (-40.00%) | 150K (-25.00%) | 200K (-23.08%) | 260K (-18.75%) | 320K (-17.95%) | 390K (-11.36%) | 440K (-63.93%) | 1.22M (-77.37%) | 5.39M (+124.58%) | 2.40M | - | - |
Other Non Operating Income | 3.12M (-74.38%) | 12M (+310.10%) | 2.97M (-7.48%) | 3.21M (-8.81%) | 3.52M (-50.35%) | 7.09M (+429.10%) | 1.34M (-20.71%) | 1.69M | -180.00K (-98.83%) | -15.45M (+225.95%) | -4.74M | - | - |
Net Income | |||||||||||||
Income Before Tax | - | -80.60M | - | - | - | -71.11M | - | - | - | -63.85M | - | - | - |
Net Income From Continuing Operations | -22.25M (-14.23%) | -25.94M (+28.61%) | -20.17M (-6.45%) | -21.56M (+66.74%) | -12.93M (-38.81%) | -21.13M (-9.74%) | -23.41M (+72.39%) | -13.58M (+4.54%) | -12.99M (-38.02%) | -20.96M (+43.37%) | -14.62M (-14.95%) | -17.19M (+55.14%) | -11.08M |
Net Income | -22.25M (-14.23%) | -25.94M (+28.61%) | -20.17M (-6.45%) | -21.56M (+66.74%) | -12.93M (-38.81%) | -21.13M (-9.74%) | -23.41M (+72.39%) | -13.58M (+4.54%) | -12.99M (-38.02%) | -20.96M (+43.37%) | -14.62M (-14.95%) | -17.19M (+55.14%) | -11.08M |
Comprehensive Income Net Of Tax | -22.46M (-72.12%) | -80.57M (+300.65%) | -20.11M (-6.94%) | -21.61M (+67.39%) | -12.91M (-81.82%) | -71.03M (+204.20%) | -23.35M (+71.69%) | -13.60M (+4.86%) | -12.97M (-79.69%) | -63.86M (+337.70%) | -14.59M | - | - |